Analysis of clinical evaluation of response to treatment of Parkinson’s disease with integrated Chinese and Western medicine therapy

Chinese Journal of Integrative Medicine

Volumn 21, Issue 1, 2015, Pages 17-21

  Li, Min ^a   Yang, Ming hui ^a   Liu, Yi ^a   Luo, Xiao dong ^b   Chen, Jian zong ^c   Shi, Heng jun ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

integrated Chinese and Western medicine therapy; means of clinical evaluation; Parkinson s disease

Indexed keywords

ADVERSE EFFECTS; AGED; CHINESE MEDICINE; CONTROLLED STUDY; FEMALE; HUMAN; INTEGRATIVE MEDICINE; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SLEEP; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTEGRATIVE MEDICINE; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PARKINSON DISEASE; SLEEP; TIME FACTORS; TREATMENT OUTCOME;

EID: 84939457611     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1760-3     Document Type: Article

References (16)

1. Sherer TB. Biomarkers for Parkinson’s disease. Sci Transl Med 2011;3:79ps14.
2. Nogawa S, Takahashi H, Hattori N. The development and validation of a new comprehensive self-completing questionnaire for symptoms in Parkinson’s disease (MASAC-PD 31). Clin Neurol 2011;51:321–329.
3. Yang MH, Li M, Dou YQ, Liu Y, Luo XD, Chen JZ, et al. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease. J Chin Integr Med (Chin) 2010;8:231–237.
4. Li M, Yang MH, Yang B. Clinical research on cerebral neurotransmitters of Parkinson’s disease with strengening Kidney and activating circulation of traditional-Chinese medicine. Heart 2013;99(Suppl 3):A282.
5. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psych 1988;51:745–752.
6. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 2001;57:1497–1499.
7. Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 2000;55:888–891.
8. Chen HB. Tanslations of the Unified Parkinson’s Disease Rating Scale (3.0,1987). Chin J Geriatic (Chin) 1999;18:61–62.
9. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, et al. Test-retest reliability of the unified Parkinson’s disease rating scale in patients with early Parkinson’s disease: results from a multicenter clinical trial. Mov Disord 2002,17:758–763.
10. Xin XL. The clinical study of repetitive transcranial magnetic stimulation on patients with Parkinson’s disease. Harbin: Heilongjiang University of Chinese Medicine, 2011.
11. Chaudhuri KR. Nocturnal symptom complex in PD and its management. Neurology 2003;61(Suppl 3):S17–S23.
12. Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ. A multicenter randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Chin J Integr Med 2011;17:669–674.
13. Zhang WT, ed. SPSS 11 statistical analysis and advanced tutorials. Beijing: Beijing Hope Electronic Press; 2002:337.
14. Li M, Yang MH, Liu Y. Effects of Chinese herb medicine Bushen Huoxue Granule on quality life of patients with Parkinson’s disease: a randomized, double-blinded and placebo-controlled trial. J Chin Integr Med (Chin) 2012;10:310–317.
15. Li M, Yang MH, Liu Y. Effects of “attenuation and synergia” for Bushen Huoxue Granules on Parkinson’s patients. J Chin Med Mater (Chin) 2012;35:503–506.
16. Porter B, Macfarlane R, Walker R. The frequency and nature of sleep disorders in a community-based population of patients with Parkinson’s disease. Eur J Neurol 2008;15:50–54.